China Pharma Holdings (CPHI) Doubles Q2 Loss to 20c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.20), versus ($0.10) reported last year. Revenue for the quarter came in at $6.1 million, versus $8 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- Haemonetics stock surges 17% on CSL Plasma supply deal update
- Starbucks (SBUX) PT Lowered to $105 at UBS as Shares Already Reflect Improved Momentum
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
